New cancer vaccine strategy
Defence Therapeutics and CQDM fund the development of a new cancer vaccine platform
06-Feb-2023 -
Defence Therapeutics and CQDM announced the launch of a collaborative research project between Université de Montréal (UdeM), the Lady Davis Institute of the Jewish General Hospital and Defence Therapeutics, a Quebec-based biotechnology company specialized in the development of next-generation ...
cancer
cancer vaccines
immunotherapies
+2